Figure 1.
The role of ex vivo chemosensitivity and chemoresistance assays (CSRA) in cancer care, a virtuous cycle. Such assays use qualified patient samples and primary culture technologies to directly test the activity of relevant anticancer drugs on a patient's own tumour cells. The resulting chemosensitivity profile is usable by physicians to fine-tune treatments.